Skip to main content

Table 4 Results of antimicrobial susceptibility testing of Cronobacter isolates.

From: Characterization of Cronobacter recovered from dried milk and related products

Isolate S S3 AMP W CN SH FR N
CFS-FSMP 1500 15.70 18.30 19.94 23.78 19.20 16.99 19.60 6.29*
CFS-FSMP 1501 17.56 28.72 25.21 29.26 21.47 22.16 21.83 17.97
CFS-FSMP 1502 16.54 28.72 20.30 22.98 21.28 22.37 21.30 17.75
CFS-FSMP 1503 18.67 24.94 23.36 25.80 23.17 22.53 23.14 18.95
CFS-FSMP 1504 17.86 30.42 21.97 24.31 22.12 23.05 22.68 17.92
CFS-FSMP 1505 18.33 29.49 22.40 26.27 21.79 24.27 22.73 19.03
CFS-FSMP 1506 18.74 31.27 22.24 25.45 23.09 23.27 23.36 19.31
CFS-FSMP 1507 17.91 30.37 22.80 25.38 21.71 28.50 23.30 18.88
CFS-FSMP 1508 17.95 32.25 22.89 27.49 20.81 21.05 23.21 17.85
CFS-FSMP 1509 18.27 23.43 22.74 26.38 21.55 22.36 22.55 17.89
CFS-FSMP 1510 17.51 26.33 22.95 7.02* 22.10 23.20 22.93 6.46*
CFS-FSMP 1511 18.37 30.95 24.75 26.40 22.30 23.23 22.46 18.53
CFS-FSMP 1512 18.53 30.55 24.78 26.90 22.63 19.83 23.41 11.95*
CFS-FSMP 1513 16.16 31.73 25.49 26.08 20.95 20.62 22.87 18.58
CFS-FSMP 1514 17.45 25.54 24.14 25.75 22.73 23.28 23.30 18.27
CFS-FSMP 1515 16.11 30.74 24.79 24.66 21.21 22.09 20.76 17.51
  1. S streptomycin, S3 compound sulphonamides, AMP ampicillin, W trimethoprim, CN gentamicin, SH spectinomycin, FR furazolidone, N neomycin; Green = susceptible, *Denotes resistance; diameter of inhibition zone was measured in mm.